Hepatitis B: Clinical Trials

1,702 trials for Hepatitis B, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

922 completed, 389 unknown, 115 recruiting, 100 terminated. 334 Phase 4, 302 Phase 2, 261 Phase 3, 218 Phase 1, 215 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 4334Completed 173, Unknown 113, Recruiting 11, Not yet recruiting 10, Terminated 9, Withdrawn 9, Active not recruiting 7, Enrolling by invitation 2
Phase 2302Completed 173, Terminated 39, Unknown 34, Recruiting 20, Active not recruiting 17, Withdrawn 11, Not yet recruiting 8
Phase 3261Completed 196, Unknown 22, Terminated 20, Not yet recruiting 9, Active not recruiting 7, Withdrawn 4, Recruiting 3
Phase 1218Completed 145, Terminated 19, Unknown 19, Recruiting 16, Not yet recruiting 10, Active not recruiting 7, Withdrawn 2
Not applicable215Completed 95, Unknown 66, Recruiting 15, Not yet recruiting 11, Withdrawn 9, Terminated 8, Active not recruiting 6, Enrolling by invitation 5
Early Phase 18Not yet recruiting 2, Unknown 2, Active not recruiting 1, Completed 1, Recruiting 1, Withdrawn 1

Follow Hepatitis B: new trials by email Literature Review of Hepatitis B trials Research Report on Hepatitis B

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
Gardasil 9 vaccine, Hepatitis B Virus Vaccine(HBV), Cognitive Behavioral Therapy - Hepatitis B, Human Papilloma Virus
Phase 4Not yet recruitingEunice Dube21402027-01-302026-07-30
Combating Related Epidemics in HCV
Cepheid GeneXpert HCV Test, Abbott Determine HIV - 1/2 Ag/Ab, Abbott Determine HbsAg 2 - HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV)
Phase 4Not yet recruitingDuke University12802027-01-202026-10-15
B-Ensure: Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants
Bepirovirsen - Hepatitis B
Phase 4Not yet recruitingGlaxoSmithKline3032026-12-032026-11-02
Targeting ANKRD11 Reverses HBV-Specific CD8+ T Cell Dysfunction and Tolerance
Chronic Hepatitis B
Not yet recruitingBeijing Municipal Administration of Hospitals402026-12-012026-08-28
A Prospective Study to Evaluate the Efficacy and Safety of Entecavir ODT Conversion in Stable Liver Transplant Patients
Entecavell ODT - Hepatitis B Virus, Liver Transplant
Phase 2Not yet recruitingJongman Kim822026-12-012026-10-28
A Study to Compare Blood Levels of Bepirovirsen and Safety Using Different Methods of Injecting in Healthy Adult Participants
Bepirovirsen - Hepatitis B
Phase 1Not yet recruitingGlaxoSmithKline982026-11-032026-10-29
HIV/HBV/HCV Triple Screening in Primary Care
electronic medical record alert linked to orders - HIV, HBV (Hepatitis B Virus)
Not applicableRecruitingUniversity of Texas Southwestern Medical Center502026-11-012026-10-29
A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)
AHB-137, Placebo, TVAX-008 - Chronic Hepatitis B
Phase 1 / Phase 2Not yet recruitingAusper Biopharma Co., Ltd.1052026-10-312026-10-19
A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)
AHB-137, TVAX-008, Placebo - Chronic Hepatitis B
Phase 1 / Phase 2Not yet recruitingGrand Theravac Life Sciences (Hangzhou) Co., Ltd.1052026-10-312026-10-27
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of ACT500 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated With Chronic Hepatitis B
ACT500 Tablets, ACT500 Placebo Tablets - Metabolic Dysfunction-associated Steatotic Liver Disease, Chronic Hepatitis b
Phase 1Not yet recruitingXiamen Amoytop Biotech Co., Ltd.242026-10-302026-09-14
A Clinical Study of AHB-121 in Healthy Participants and Chronic Hepatitis B (CHB) Participants
AHB-121, Placebo - Chronic Hepatitis B Virus
Phase 1Not yet recruitingAusper Biopharma Co., Ltd.1102026-10-282026-10-21
Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness
Wearable Patch-Type Ultrasound Probe, Transient Elastography (FibroScan) - Liver Fibrosis, Liver Cirrhosis
Not yet recruitingSecond Affiliated Hospital of Xi'an Jiaotong University1502026-10-012026-07-21
Study Interchangeability Hep-B Vaccine Administered at Birth Dose
In-house Hepatitis B Vaccine, Registered Hepatitis B Vaccine - Vaccination Adverse Event, Immunogenicity, Vaccine
Phase 3Not yet recruitingPT Bio Farma2702026-10-012026-10-02
Study of BK1803 in Healthy Infants
BK1803, GOBIK Aqueous Suspension Syringes, Bimmugen® Injection - Pertussis, Diphtheria
Phase 3Not yet recruitingTanabe Pharma Corporation3442026-10-012026-08-28
Phase Ia/Ib Trial of SCTA02A Injection in Healthy Adults and Patients With Chronic Hepatitis B
SCTA02A, Placebo - Hepatitis B
Phase 1Not yet recruitingSinocelltech Ltd.602026-10-012026-10-29
Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)
Hepatocellular Carcinoma, Liver Cirrhosis
Not yet recruitingD'Or Institute for Research and Education3002026-09-152026-08-14
Strengthening, Guidance, Health, Empowerment
Self-sampling for six sexually transmitted infections - HIV Infection, Syphilis
Not applicableNot yet recruitingUniversity Hospital, Montpellier2002026-09-012026-08-26
A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection
WGc0201 - Chronic Hepatitis B Virus (Hbv)
Phase 1RecruitingJiyan Liu92026-09-012026-07-01
Hepatitis B Infection Surveillance
Chronic Hepatitis B Infection
Not yet recruitingAssistance Publique - HĂ´pitaux de Paris13602026-09-012026-07-27
Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response
TQA3605 tablets Placebo, TQA3605 tablets, Entecavir dispersible tablets - Chronic Hepatitis B
Phase 3Not yet recruitingChia Tai Tianqing Pharmaceutical Group Co., Ltd.9302026-09-012026-10-02

Showing 20 of 1702. Sign in to see all of them.

Narrower conditions

Hepatitis B, Chronic (863)  ·  Hepatitis C (109)  ·  Tetanus (105)  ·  Diphtheria (101)  ·  Haemophilus Infections (82)  ·  Carcinoma, Hepatocellular (81)  ·  Liver Cirrhosis (72)  ·  Whooping Cough (72)  ·  Poliomyelitis (68)  ·  HIV Infections (66)  ·  Hepatitis (58)  ·  Fibrosis (53)  ·  Liver Diseases (32)  ·  Acquired Immunodeficiency Syndrome (30)

Broader conditions

Hepadnaviridae Infections (1702)  ·  Blood-Borne Infections (1700)  ·  Digestive System Diseases (1698)  ·  DNA Virus Infections (1696)  ·  Hepatitis, Viral, Human (1694)  ·  Communicable Diseases (1693)  ·  Infections (1687)  ·  Virus Diseases (1682)  ·  Liver Diseases (1670)  ·  Hepatitis (1644)  ·  Pathological Conditions, Signs and Symptoms (979)  ·  Pathologic Processes (973)  ·  Disease Attributes (908)  ·  Chronic Disease (884)  ·  Hepatitis, Chronic (855)

Interventions

entecavir (198)  ·  Tenofovir (166)  ·  peginterferon alfa-2a (110)  ·  Hepatitis B Vaccines (75)  ·  Lamivudine (64)  ·  tenofovir alafenamide (61)  ·  adefovir dipivoxil (54)  ·  Telbivudine (51)  ·  Engerix-B (49)  ·  adefovir (37)  ·  diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (25)  ·  peginterferon alfa-2b (24)  ·  clevudine (21)  ·  Blood Specimen Collection (20)  ·  hepatitis B hyperimmune globulin (18)

Sponsors

GlaxoSmithKline (159)  ·  Hoffmann-La Roche (47)  ·  Gilead Sciences (44)  ·  Third Affiliated Hospital, Sun Yat-Sen University (39)  ·  Bristol-Myers Squibb (35)  ·  National Taiwan University Hospital (30)  ·  Beijing Ditan Hospital (28)  ·  Sanofi Pasteur, a Sanofi Company (28)  ·  Nanfang Hospital, Southern Medical University (25)  ·  Merck Sharp & Dohme LLC (19)  ·  Assembly Biosciences (17)  ·  Bukwang Pharmaceutical (17)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (17)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (16)  ·  The University of Hong Kong (16)

Countries

China (487)  ·  United States (262)  ·  South Korea (188)  ·  Taiwan (145)  ·  Canada (117)  ·  France (113)  ·  Hong Kong (107)  ·  New Zealand (98)  ·  Germany (95)  ·  Thailand (90)  ·  United Kingdom (89)  ·  Australia (83)  ·  Spain (71)  ·  Belgium (67)  ·  Italy (67)

Top investigators

Liang Peng, Doctor (13)  ·  Marc G Ghany, M.D. (7)  ·  Guiqiang Wang (6)  ·  Jinlin Hou (6)  ·  Junqi Niu (6)  ·  Hong Ren, MM (5)  ·  Hong You, Doctor (5)

Results publications

PMID 28427875, PMID 19052126, PMID 24915612, PMID 28404091, PMID 28404092, PMID 29405329, PMID 33460002, PMID 35599306, PMID 15470215, PMID 19187608, PMID 21182232, PMID 22436845, PMID 23046671, PMID 23518903, PMID 25987775, PMID 27658343, PMID 32710245, PMID 35941076, PMID 42550463, PMID 15014185, PMID 16391218, PMID 16525137, PMID 16525138, PMID 17716936, PMID 18094378, PMID 19729084, PMID 20009522, PMID 20049753, PMID 20091678, PMID 20657177, PMID 20955704, PMID 21366801, PMID 22045673, PMID 22508412, PMID 22777097, PMID 23234725, PMID 23364953, PMID 23732904, PMID 23939953, PMID 24954675, PMID 25179493, PMID 25277773, PMID 25348661, PMID 25532501, PMID 25788199, PMID 27257978, PMID 28215615, PMID 28340322, PMID 29289383, PMID 29696665

NIH funding

2014 (10), 2016 (9), 2019 (9), 2009 (7), 2015 (7), 2017 (7), U01DK082864 (7), 2023 (5), U01DK082843 (5), U01DK082871 (5), U01DK082874 (5), U01DK082944 (5), UL1TR000004 (5), 2018 (3), M01RR000040 (3)